News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
743,354 Results
Type
Article (52972)
Company Profile (297)
Press Release (690085)
Section
Business (214954)
Career Advice (2855)
Deals (36978)
Drug Delivery (117)
Drug Development (85752)
Employer Resources (181)
FDA (16978)
Job Trends (15786)
News (364915)
Policy (35298)
Tag
Academia (2889)
Alliances (52565)
Alzheimer's disease (1403)
Approvals (16936)
Artificial intelligence (220)
Bankruptcy (383)
Best Places to Work (12183)
Biotechnology (214)
Breast cancer (239)
Cancer (1803)
Cardiovascular disease (142)
Career advice (2389)
CAR-T (131)
Cell therapy (379)
Clinical research (68835)
Collaboration (698)
Compensation (376)
COVID-19 (2764)
C-suite (173)
Data (1661)
Diabetes (226)
Diagnostics (6640)
Earnings (87182)
Employer resources (157)
Events (117246)
Executive appointments (594)
FDA (17910)
Funding (628)
Gene therapy (272)
GLP-1 (738)
Government (4801)
Healthcare (20010)
Infectious disease (2883)
Inflammatory bowel disease (130)
Interviews (553)
IPO (16898)
Job creations (4060)
Job search strategy (1976)
Layoffs (489)
Legal (8682)
Lung cancer (273)
Manufacturing (253)
Medical device (13926)
Medtech (13931)
Mergers & acquisitions (20445)
Metabolic disorders (602)
Neuroscience (1848)
NextGen: Class of 2025 (7118)
Non-profit (4883)
Northern California (2126)
Obesity (336)
Opinion (240)
Patents (171)
People (61448)
Phase I (21393)
Phase II (30223)
Phase III (22561)
Pipeline (734)
Postmarket research (2910)
Preclinical (9117)
Radiopharmaceuticals (251)
Rare diseases (349)
Real estate (6379)
Regulatory (23656)
Research institute (2551)
Resumes & cover letters (452)
Southern California (1823)
Startups (3852)
United States (19032)
Vaccines (685)
Weight loss (245)
Date
Today (11)
Last 7 days (621)
Last 30 days (2603)
Last 365 days (35790)
2025 (4648)
2024 (36652)
2023 (41587)
2022 (52797)
2021 (57466)
2020 (56333)
2019 (49551)
2018 (37499)
2017 (34361)
2016 (34236)
2015 (40296)
2014 (34215)
2013 (29597)
2012 (31653)
2011 (32196)
2010 (30409)
Location
Africa (911)
Arizona (222)
Asia (41959)
Australia (7654)
California (4871)
Canada (1737)
China (409)
Colorado (222)
Connecticut (240)
Europe (92907)
Florida (700)
Georgia (168)
Illinois (488)
Indiana (268)
Maryland (777)
Massachusetts (3726)
Michigan (204)
Minnesota (351)
New Jersey (1375)
New York (1387)
North Carolina (907)
Northern California (2126)
Ohio (176)
Pennsylvania (1115)
South America (1288)
Southern California (1823)
Texas (713)
Utah (146)
Washington State (484)
743,354 Results for "fabric genomics formerly known as omicia inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Business
Fabric Genomics Partners with Intermountain Children’s Health to Enhance Precision Diagnosis of Infants and Children Using Whole Genome Sequencing from Broad Clinical Labs
Fabric Genomics is announcing a new partnership with Intermountain Children’s Health to analyze the whole genomes of children sequenced by the Broad Clinical Labs to help speed diagnosis of kids who may have genetic diseases.
March 13, 2024
·
5 min read
Press Releases
Pharming to nominate biopharmaceutical leader Fabrice Chouraqui as new Executive Director and Chief Executive Officer
January 21, 2025
·
9 min read
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
Deals
Fabric Acquires MeMD, Expanding Virtual Care Services to 30,000 Employers and 5 Million Members
Fabric, a leading healthcare technology company and care enablement system, announced the acquisition of MeMD from Walmart Inc. MeMD is a leading provider of virtual behavioral, urgent, and primary care benefits for 30,000 corporate, institutional, and health plan partners and 5 million members.
June 28, 2024
·
3 min read
Oxford Nanopore Technologies and Fabric Genomics Collaborate to Launch an Integrated Whole-Genome Sequencing Solution to Advance the Future of Paediatric Patient Care
Oxford Nanopore Technologies plc and Fabric Genomics announced a new collaboration to develop a scalable software solution for the end-to-end analysis and clinical reporting of rich genomic data.
October 31, 2023
·
5 min read
Business
Align Technology Appoints Emory Wright, EVP Direct Fabrication Manufacturing Platform to Build the Company’s Next Generation Manufacturing Operations -- Wright Plans to Retire in 2026
Align Technology, Inc. today announced it has appointed Emory Wright, executive vice president, direct fabrication manufacturing platform, effective immediately.
May 22, 2024
·
5 min read
Press Releases
Moss Genomics Inc. Announces Successful German Listing on the Frankfurt Stock Exchange (FSE)
January 14, 2025
·
5 min read
BioMidwest
New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
Baxter International Inc. announced new data showing expanded hemodialysis, known as HDx therapy, enabled by Theranova dialyzer, was associated with an approximately 25% lower all-cause mortality risk for up to four years when compared to high-flux hemodialysis.
May 29, 2024
·
5 min read
Press Releases
Pentixapharm Receives EUR 6.77 Million for Intangible Assets Formerly Developed by Glycotope
January 7, 2025
·
1 min read
1 of 74,336
Next
